Success Metrics

Clinical Success Rate
100.0%

Based on 25 completed trials

Completion Rate
100%(25/25)
Active Trials
0(0%)
Results Posted
16%(4 trials)

Phase Distribution

Ph phase_4
1
4%
Ph not_applicable
13
46%
Ph phase_3
1
4%
Ph early_phase_1
2
7%
Ph phase_1
5
18%
Ph phase_2
5
18%

Phase Distribution

7

Early Stage

5

Mid Stage

2

Late Stage

Phase Distribution27 total trials
Early Phase 1First-in-human
2(7.4%)
Phase 1Safety & dosage
5(18.5%)
Phase 2Efficacy & side effects
5(18.5%)
Phase 3Large-scale testing
1(3.7%)
Phase 4Post-market surveillance
1(3.7%)
N/ANon-phased studies
13(48.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

96.2%

25 of 26 finished

Non-Completion Rate

3.8%

1 ended early

Currently Active

0

trials recruiting

Total Trials

28

all time

Status Distribution
Completed(25)
Terminated(1)
Other(2)

Detailed Status

Completed25
unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
28
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (7.4%)
Phase 15 (18.5%)
Phase 25 (18.5%)
Phase 31 (3.7%)
Phase 41 (3.7%)
N/A13 (48.1%)

Trials by Status

completed2589%
withdrawn14%
unknown27%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT00210132Phase 2

Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery

Completed
NCT06003465Phase 1

A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices

Completed
NCT05414474Not Applicable

Effects of Enhancers and Inhibitors on Absorption From Iron Supplements

Completed
NCT06037512Not Applicable

User Evaluation of BGM VGM77

Completed
NCT02995694Phase 3

A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis

Completed
NCT05085587Phase 1

Bioequivalence Study of Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Unknown
NCT04746040Phase 1

A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Unknown
NCT04790838

Pooled Analysis FP_SX_250_50

Completed
NCT03567941Phase 1

To Evaluate the Relative Abuse Potential of Hydrocodone Bitartrate and Acetaminophen

Completed
NCT02746731Not Applicable

Prehabilitation - Enhanced Recovery After Colorectal Surgery

Completed
NCT03167541Phase 1

Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study

Completed
NCT03573635Not Applicable

Continuous Supraglottic Aspiration in Intubated and Mechanically Ventilated Patients: the "SUPRAtube" Device

Completed
NCT03275948Not Applicable

Effects of Whole Grain Rye on Metabolic Risk Markers and Mood

Completed
NCT01425814Phase 2

Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population

Completed
NCT02413671Not Applicable

The Role of Whey and Lupin in Glycemic Control (Nutritional Pre-Study)

Completed
NCT02876029Not Applicable

Food Design for Improved Day-long Glycaemic Regulation

Completed
NCT02743130Not Applicable

Effects of Berry Nectars Sweetened With Inverted Sugar on Post-meal Blood Sugar

Completed
NCT02047669Not Applicable

Implementation of Physical Exercise at the Workplace (IRMA09) - Laboratory Technicians

Completed
NCT01360944Phase 2

Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test

Completed
NCT01119339Phase 2

Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis

Completed

Drug Details

Intervention Type
OTHER
Total Trials
28